153 related articles for article (PubMed ID: 31646564)
1. Reduced serum miR-98 predicts unfavorable clinical outcome of colorectal cancer.
Wang YG; He Q; Guo SQ; Shi ZZ
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8345-8353. PubMed ID: 31646564
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
Wang DS; Zhong B; Zhang MS; Gao Y
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
[TBL] [Abstract][Full Text] [Related]
3. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer.
Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z
Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615
[TBL] [Abstract][Full Text] [Related]
4. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
5. Serum miR-199a as a potential diagnostic biomarker for detection of colorectal cancer.
Tan HY; Zheng YB; Liu J
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8657-8663. PubMed ID: 30575906
[TBL] [Abstract][Full Text] [Related]
6. Reduced serum exosomal miR-874 expression predicts poor prognosis in colorectal cancer.
Zhang N; Zhang PP; Huang JJ; Wang ZY; Zhang ZH; Yuan JZ; Ma EM; Liu X; Bai J
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):664-672. PubMed ID: 32016967
[TBL] [Abstract][Full Text] [Related]
7. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
8. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer.
Hao JP; Ma A
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8649-8656. PubMed ID: 30575905
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
10. Plasma miR-183 predicts recurrence and prognosis in patients with colorectal cancer.
Yuan D; Li K; Zhu K; Yan R; Dang C
Cancer Biol Ther; 2015; 16(2):268-75. PubMed ID: 25629978
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.
Basati G; Razavi AE; Pakzad I; Malayeri FA
Tumour Biol; 2016 Feb; 37(2):1781-8. PubMed ID: 26318304
[TBL] [Abstract][Full Text] [Related]
12. Low Serum Levels of miR-101 Are Associated with Poor Prognosis of Colorectal Cancer Patients After Curative Resection.
He D; Yue Z; Li G; Chen L; Feng H; Sun J
Med Sci Monit; 2018 Oct; 24():7475-7481. PubMed ID: 30341274
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
14. Serum
Wang N; Zeng L; Li Z; Zhen Y; Chen H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
[TBL] [Abstract][Full Text] [Related]
15. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
17. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
18. Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.
Toiyama Y; Takahashi M; Hur K; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
J Natl Cancer Inst; 2013 Jun; 105(12):849-59. PubMed ID: 23704278
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of serum microRNA-21 in colorectal cancer.
Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
[TBL] [Abstract][Full Text] [Related]
20. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis.
Ling H; Pickard K; Ivan C; Isella C; Ikuo M; Mitter R; Spizzo R; Bullock M; Braicu C; Pileczki V; Vincent K; Pichler M; Stiegelbauer V; Hoefler G; Almeida MI; Hsiao A; Zhang X; Primrose J; Packham G; Liu K; Bojja K; Gafà R; Xiao L; Rossi S; Song JH; Vannini I; Fanini F; Kopetz S; Zweidler-McKay P; Wang X; Ionescu C; Irimie A; Fabbri M; Lanza G; Hamilton SR; Berindan-Neagoe I; Medico E; Mirnezami A; Calin GA; Nicoloso MS
Gut; 2016 Jun; 65(6):977-989. PubMed ID: 25804630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]